Re: Clinical Efficacy of Collagenase Clostridium Histolyticum in the Treatment of Peyronie's Disease by Subgroup: Results from two Large, Double-Blind, Randomized, Placebo-Controlled, Phase III Studies Editorial Comment

被引：0
|
作者：
Seftel, Allen D.
机构：
来源：
JOURNAL OF UROLOGY | 2015年 / 194卷 / 05期
关键词：
D O I：
10.1016/j.juro.2015.07.058
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1365 / 1365
页数：1
相关论文
共 50 条
  • [21] A Double-Blind Placebo-Controlled Study of the Efficacy and Safety of Pentoxifylline in Early Chronic Peyronie's Disease Editorial Comment
    Seftel, Allen D.
    JOURNAL OF UROLOGY, 2010, 184 (01): : 244 - 245
  • [22] A Double-Blind Placebo-Controlled Study of the Efficacy and Safety of Pentoxifylline in Early Chronic Peyronie's Disease Editorial Comment
    Seftel, Allen
    JOURNAL OF UROLOGY, 2010, 184 (03): : 1073 - 1073
  • [23] Apremilast for Behcet's syndrome: results from a phase III, randomized, double-blind, placebo-controlled study in a Japanese subgroup
    Kono, H.
    Dobashi, H.
    Tanaka, Y.
    Sugii, S.
    Kishimoto, M.
    Cheng, S.
    Mccue, S.
    Paris, M.
    Takeno, M.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2018, 36 (06) : S182 - S182
  • [24] Apremilast for Behcet's Syndrome: Results from a Phase III, Randomized, Double-Blind, Placebo-Controlled Study in a Japanese Subgroup
    Takeno, Mitsuhiro
    Tanaka, Yoshiva
    Kono, Hajime
    Sugii, Shouji
    Kishimoto, Mitsumasa
    Chene, Sue
    McCue, Shannon
    Paris, Maria
    Dobashi, Hiroaki
    ARTHRITIS & RHEUMATOLOGY, 2018, 70
  • [25] Collagenase Clostridium Histolyticum-aaes for the Treatment of Cellulite in Women: Results From Two Phase 3 Randomized, Placebo-Controlled Trials
    Kaufman-Janette, Joely
    Joseph, John H.
    Kaminer, Michael S.
    Clark, James
    Fabi, Sabrina G.
    Gold, Michael H.
    Goldman, Mitchel P.
    Katz, Bruce E.
    Peddy, Kappa
    Schlessinger, Joel
    Young, V. Leroy
    Davis, Matthew
    Hurley, David
    Liu, Genzhou
    McLane, Michael P.
    Vijayan, Saji
    Bass, Lawrence S.
    DERMATOLOGIC SURGERY, 2021, 47 (05) : 649 - 656
  • [26] Editorial Comment on: A First Prospective, Randomized, Double-Blind, Placebo-Controlled Clinical Trial Evaluating Extracorporeal Shock Wave Therapy for the Treatment of Peyronie's Disease
    Morales, Antonio Martin
    EUROPEAN UROLOGY, 2009, 56 (02) : 369 - 370
  • [27] Re: Plaque Calcification: An Important Predictor of Collagenase Clostridium Histolyticum Treatment Outcomes for Men with Peyronie's Disease Editorial Comment
    Seftel, Allen D.
    JOURNAL OF UROLOGY, 2018, 200 (05): : 928 - 928
  • [28] Inhaled Lidocaine for the Treatment of Asthma: Lack of Efficacy in Two Double-Blind, Randomized, Placebo-Controlled Clinical Studies
    Abuan, Tammy
    Yeager, Melissa
    Montgomery, A. Bruce
    JOURNAL OF AEROSOL MEDICINE AND PULMONARY DRUG DELIVERY, 2010, 23 (06) : 381 - 388
  • [29] Efficacy and safety of oxycodone DETERx: results of a randomized, double-blind, placebo-controlled phase III study
    Kopecky, E.
    O'Connor, M.
    Varanasi, R.
    Saim, S.
    Fleming, A.
    JOURNAL OF PAIN, 2015, 16 (04): : S87 - S87
  • [30] Liposomal recombinant human superoxide dismutase for the treatment of Peyronie's disease:: A randomized placebo-controlled double-blind clinical study
    Riedl, CR
    Sternig, P
    Langmann, F
    Galle, G
    Engelhardt, PF
    Vcelar, B
    Vorauer, K
    Wagner, A
    Katinger, H
    Pflüger, H
    JOURNAL OF UROLOGY, 2005, 173 (04): : 253 - 254
12345